Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 85 (RPL21P85) is a processed pseudogene in the human genome, originating from the gene encoding ribosomal protein L21[1][11]. Processed pseudogenes arise when reverse-transcribed mRNA is inserted into the genome, typically resulting in nonfunctional sequences due to lack of regulatory elements or disabling mutations[2]. RPL21P85 does not produce a protein and is not known to play a regulatory or functional role. Its presence is typical of ribosomal protein genes, which often have many pseudogenes dispersed through the genome due to their high expression and retrotranspositional activity[2][1][7]. There is no evidence that RPL21P85 acts as a receptor, enzyme, transporter, or other druggable target[1][3][11]. The associated functional gene, ribosomal protein L21 (RPL21), is implicated in ribosome assembly and several diseases, but the pseudogene itself has no known direct association with pathology or therapeutics[9][11][7].\n\nKey clarifications:\n- RPL21P85 is not a receptor, enzyme, transporter, or functional protein[1][11].\n- It is not considered a drug target and has no known biological, disease, or biomarker relevance[1][11].\n- The functional gene RPL21 (not the pseudogene) is related to ribosomal protein function and associated with certain genetic diseases, but this does not apply to RPL21P85[5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 85 (RPL21P85).